Akili, Inc. (AKLI) is a publicly traded company in the Healthcare sector, operating within the Medical - Healthcare Information Services industry. The company is headquartered in Boston, MA, United States. The current CEO is Matthew Franklin.
AKLI has IPO date of 2021-06-30, 68 full-time employees, listed on the NASDAQ Capital Marke, a market capitalization of $34.1M.
Akili, Inc., a digital medicine company, develops digital therapeutics for cognitive impairments. It provides EndeavorRx, a physician-prescribed video game-based treatment designed to directly target cognitive functioning. The company is based in Boston, Massachusetts.
